[Monoamine oxidase activity in rat liver in vitamin B12 deficiency]. 1995

N N Gessler, and N I Fedotcheva, and A G Foĭgel', and N V Alekseeva, and M N Kondrashova, and V Ia Bykhovskiĭ

Changes in the activity of monoamine oxidase (MAO-B) in liver homogenates and mitochondria from normal and vitamin B12-deficient rats have been studied in various functional states of the mitochondria. Preincubation of liver preparation at 32 degrees C increased the MAO affinity for benzylamine in samples of normal (but not vitamin B12-deficient rats). Succinate added to the incubation medium decreased Km and increased Vmax in both normal and vitamin B12-deficient animals. A correlation was found between the decline of MAO-B activity under vitamin B12 deficiency, deceleration of succinate oxidation and reduction of the transmembrane potential.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008564 Membrane Potentials The voltage differences across a membrane. For cellular membranes they are computed by subtracting the voltage measured outside the membrane from the voltage measured inside the membrane. They result from differences of inside versus outside concentration of potassium, sodium, chloride, and other ions across cells' or ORGANELLES membranes. For excitable cells, the resting membrane potentials range between -30 and -100 millivolts. Physical, chemical, or electrical stimuli can make a membrane potential more negative (hyperpolarization), or less negative (depolarization). Resting Potentials,Transmembrane Potentials,Delta Psi,Resting Membrane Potential,Transmembrane Electrical Potential Difference,Transmembrane Potential Difference,Difference, Transmembrane Potential,Differences, Transmembrane Potential,Membrane Potential,Membrane Potential, Resting,Membrane Potentials, Resting,Potential Difference, Transmembrane,Potential Differences, Transmembrane,Potential, Membrane,Potential, Resting,Potential, Transmembrane,Potentials, Membrane,Potentials, Resting,Potentials, Transmembrane,Resting Membrane Potentials,Resting Potential,Transmembrane Potential,Transmembrane Potential Differences
D008995 Monoamine Oxidase An enzyme that catalyzes the oxidative deamination of naturally occurring monoamines. It is a flavin-containing enzyme that is localized in mitochondrial membranes, whether in nerve terminals, the liver, or other organs. Monoamine oxidase is important in regulating the metabolic degradation of catecholamines and serotonin in neural or target tissues. Hepatic monoamine oxidase has a crucial defensive role in inactivating circulating monoamines or those, such as tyramine, that originate in the gut and are absorbed into the portal circulation. (From Goodman and Gilman's, The Pharmacological Basis of Therapeutics, 8th ed, p415) EC 1.4.3.4. Amine Oxidase (Flavin-Containing),MAO,MAO-A,MAO-B,Monoamine Oxidase A,Monoamine Oxidase B,Type A Monoamine Oxidase,Type B Monoamine Oxidase,Tyramine Oxidase,MAO A,MAO B,Oxidase, Monoamine,Oxidase, Tyramine
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014805 Vitamin B 12 A cobalt-containing coordination compound produced by intestinal micro-organisms and found also in soil and water. Higher plants do not concentrate vitamin B 12 from the soil and so are a poor source of the substance as compared with animal tissues. INTRINSIC FACTOR is important for the assimilation of vitamin B 12. Cobalamin,Cyanocobalamin,Cobalamins,Eritron,Vitamin B12,B 12, Vitamin,B12, Vitamin
D014806 Vitamin B 12 Deficiency A nutritional condition produced by a deficiency of VITAMIN B 12 in the diet, characterized by megaloblastic anemia. Since vitamin B 12 is not present in plants, humans have obtained their supply from animal products, from multivitamin supplements in the form of pills, and as additives to food preparations. A wide variety of neuropsychiatric abnormalities is also seen in vitamin B 12 deficiency and appears to be due to an undefined defect involving myelin synthesis. (From Cecil Textbook of Medicine, 19th ed, p848) Deficiency, Vitamin B 12,Deficiency, Vitamin B12,Vitamin B12 Deficiency,Deficiencies, Vitamin B12,Vitamin B12 Deficiencies
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

N N Gessler, and N I Fedotcheva, and A G Foĭgel', and N V Alekseeva, and M N Kondrashova, and V Ia Bykhovskiĭ
May 1994, Biological psychiatry,
N N Gessler, and N I Fedotcheva, and A G Foĭgel', and N V Alekseeva, and M N Kondrashova, and V Ia Bykhovskiĭ
January 1957, Bollettino della Societa italiana di biologia sperimentale,
N N Gessler, and N I Fedotcheva, and A G Foĭgel', and N V Alekseeva, and M N Kondrashova, and V Ia Bykhovskiĭ
July 1964, The Tohoku journal of experimental medicine,
N N Gessler, and N I Fedotcheva, and A G Foĭgel', and N V Alekseeva, and M N Kondrashova, and V Ia Bykhovskiĭ
January 1957, Bollettino della Societa italiana di biologia sperimentale,
N N Gessler, and N I Fedotcheva, and A G Foĭgel', and N V Alekseeva, and M N Kondrashova, and V Ia Bykhovskiĭ
April 1967, The American journal of clinical nutrition,
N N Gessler, and N I Fedotcheva, and A G Foĭgel', and N V Alekseeva, and M N Kondrashova, and V Ia Bykhovskiĭ
January 1957, Bollettino della Societa italiana di biologia sperimentale,
N N Gessler, and N I Fedotcheva, and A G Foĭgel', and N V Alekseeva, and M N Kondrashova, and V Ia Bykhovskiĭ
April 1955, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
N N Gessler, and N I Fedotcheva, and A G Foĭgel', and N V Alekseeva, and M N Kondrashova, and V Ia Bykhovskiĭ
September 1994, Japanese journal of pharmacology,
N N Gessler, and N I Fedotcheva, and A G Foĭgel', and N V Alekseeva, and M N Kondrashova, and V Ia Bykhovskiĭ
October 1978, Archives of biochemistry and biophysics,
N N Gessler, and N I Fedotcheva, and A G Foĭgel', and N V Alekseeva, and M N Kondrashova, and V Ia Bykhovskiĭ
January 1971, Experientia,
Copied contents to your clipboard!